FTC Tells Medtronic To Sell Intersect ENT Subsidiary To Avoid Monopoly
Executive Summary
The move removes all regulatory roadblocks to Medtronic’s $1.1bn acquisition of Intersect ENT, which was announced in August 2021.
You may also be interested in...
Medtronic Bolsters Sinus Portfolio With $1.1Bn Intersect ENT Buyout
Medtronic announced plans to acquire Intersect ENT, adding its sinus implants to Medtronic's portfolio of devices used by surgeons in treating chronic rhinosinusitis.
MDUFA V Passed By US House Health Subcommittee
The user fee package was among several health-related bills that the subcommittee took up on Wednesday.
Jury Awards Nearly $334M To MGI Tech In Illumina Patent Suit
The jury said the infringement, which involved patents on two-channel sequencing chemistry technology, had been “willful” and turned down Illumina’s counterclaims.